|
PLEASE NOTE:
Online presentations from the Thimerosal and Neurodevelopmental Outcomes meeting are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read here.
Internet Explorer is recommended for viewing the slides and transcript. Some presentations may not be accessible with Netscape Navigator. Most presentations are available as PDF files which require Adobe Acrobat Reader. Click here to download Adobe Acrobat Reader for free.
The audiocast segments require RealPlayer. Click here to download RealPlayer 8 Basic for free.
Due to the poor sound quality of some presentations, the meeting transcript has been made available in PDF file.
Thimerosal-Containing Vaccines and
Neurodevelopmental Outcomes
Meeting Agenda
Cambridge, MA
Monday, July 16, 2001
Welcome and Introductions
Marie McCormick, MD, ScD
Chair, Immunization Safety Review Committee
Audio
Risk Assessment of Thimerosal in Childhood Vaccines
Leslie K. Ball, MD
Division of Vaccines and Related Product Applications
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
Food and Drug Administration
Slides
Audio
History of Thimerosal Concern and Comparative Policy Actions
Gary L. Freed, MD
The Percy and Mary Murphy Professor of Pediatrics and Child Health Delivery
Director, Division of General Pediatrics
Professor of Health Management and Policy
University of Michigan
Slides
Audio
Margie Andreae, MD
Associate Director for Clinical Services
Division of General Pediatrics
University of Michigan
Slides are unavailable
Audio
Biologic Plausibility and Planned Research
Jane M. El-Dahr, MD
Head, Section of Pediatric Allergy, Immunology, Rheumatology
Tulane University Health Sciences Center
Slides
Audio
David S. Baskin, MD
Professor of Neurosurgery
Baylor College of Medicine
Slides
Audio
The Role of Heavy Metals in Autism
Jeffrey Bradstreet, MD
Director of Research
The International Autism Research Center
Slides
Audio
Pharmacokinetic Modeling of Hair Mercury Levels from Thimerosal
David Brown, ScD
Toxicologist and Independent Consultant
Connecticut
Paper
Audio
Vaccine Safety Datalink (VSD) Screening Study and Follow-up Analysis with Harvard Pilgrim Data
Thomas Verstraeten, MD, MSc
EIS Officer, National Immunization Program
Centers for Disease Control and Prevention
Slides
Audio
Protocol for National Immunization Program Study on Thimerosal
Paul Stehr-Green, DrPH, MPH
Associate Professor of Epidemiology
University of Washington School of Community Medicine and Public Health
Slides
Audio
William Thompson, PhD (for Q&A period only)
Epidemiologist, National Immunization Program
Centers for Disease Control and Prevention
Seychelles Islands Study
Gary Myers, MD
Professor of Neurology and Pediatrics
University of Rochester School of Medicine and Dentistry
Slides
Audio
Faroe Islands Study
Philippe Grandjean, MD, DMSc
Institute of Community Health
Odense University, Denmark
Slides are unavailable
Audio
In Vitro Studies of Thimerosal Toxicity
Boyd E. Haley, PhD
Chairman and Professor, Department of Chemistry
University of Kentucky
Slides
Audio
Comparative Toxicology of Ethyl and Methyl Mercury
George Lucier, PhD
Former Director, Environmental Toxicology Program
National Institute for Environmental Health Sciences
Slides
Audio
Rising Incidence of Autism: Association with Thimerosal
Mark F. Blaxill, MBA
Autism Society of America, Massachusetts Chapter
Slides
Audio
NIH Studies on Thimerosal
Polly Sager, PhD
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Slides
Audio
Wrap-up Commentary on Thimerosal Risk
From the Perspective of a Developmental Toxicologist
George Lambert, MD
Environmental and Occupational Health Sciences Institute
Robert Wood Johnson Medical School
Slides
Audio
Wrap-up Commentary on Thimerosal Risk from the Perspective of a Pediatric Vaccinologist
Neal Halsey, MD
Professor and Director
Division of Disease Control
Department of International Health
Johns Hopkins University
Slides
Audio
Public comments
Audio
Return to Thimerosal and Neurodevelopmental Outcomes page
Back to the Immunization Safety Review main page
Page last updated May 29, 2003
|